Injectable testosterone and dutasteride recalled for lack of sterility assurance
Talon Compounding Pharmacy is recalling 21 vials of injectable testosterone cypionate/dutasteride because the manufacturer cannot assure sterility of the product. The recall affects distribution across the United States, Washington D.C., and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. Lack of sterility assurance on injectable medications represents a significant risk of serious infection, which aligns with the Severe category for Class II recalls where serious harm is possible without reported illness yet being documented.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling TEST CYPIONATE 200MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE across the United States, including Washington, D.C. and Puerto Rico. The product is a prescription-only injectable medication distributed by Talon Compounding Pharmacy in San Antonio, Texas.
The recall was initiated because the manufacturer cannot assure sterility of the product. Non-sterile injectable medications can introduce bacterial or fungal contamination that poses a serious health risk to patients.
Six lots are affected: T1006042021:53 (BUD 12/01/2021), T1008192021:83 (BUD 02/15/2022), T1005212021:52 (BUD 11/17/2021), T1009072021:35 (BUD 03/06/2022), T1007132021:61 (BUD 01/09/2022), and T1009142021:95 (BUD 03/13/2022). A total of 21 vials are affected.
Patients who have received this product should contact their healthcare provider immediately. Healthcare providers and pharmacists should stop dispensing the product and quarantine all remaining stock.
The recalled product
- Product
- TEST CYPIONATE 200MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Category
- Drug — Injectable / Compounded
- Hazard
- sterility-failure
- infection-risk
- bacterial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot: T1006042021:53 BUD: 12/01/2021
- T1008192021:83 BUD: 02/15/2022
- T1005212021:52 BUD: 11/17/2021
- T1009072021:35 BUD: 03/06/2022
- T1007132021:61 BUD: 01/09/2022
- T1009142021:95 BUD: 03/13/2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27